↓ Skip to main content

Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Overview of attention for article published in Frontiers in oncology, October 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Published in
Frontiers in oncology, October 2020
DOI 10.3389/fonc.2020.576924
Pubmed ID
Authors

Jonathan Pan, Daniel Altman, Lindsay Wilde

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 33%
Student > Doctoral Student 1 6%
Other 1 6%
Student > Ph. D. Student 1 6%
Professor > Associate Professor 1 6%
Other 0 0%
Unknown 8 44%
Readers by discipline Count As %
Medicine and Dentistry 8 44%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Engineering 1 6%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2022.
All research outputs
#7,361,749
of 25,387,668 outputs
Outputs from Frontiers in oncology
#2,601
of 22,433 outputs
Outputs of similar age
#155,732
of 438,879 outputs
Outputs of similar age from Frontiers in oncology
#98
of 692 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,879 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 692 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.